CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top player positioning, 2019

3.3.Porter's five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Rise in initiatives by pharma companies to enhance vaccine R&D
3.4.1.2.Growth in awareness among people about the advantages of DTP vaccines

3.4.2.Restraints

3.4.2.1.Inadequate access to vaccines in under developed countries
3.4.2.2.High cost of vaccine development

3.4.3.Opportunities

3.4.3.1.Innovative vaccine technologies

CHAPTER 4:DTP VACCINES MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.DTaP Vaccines

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.TD Vaccines

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Tdap Vaccines

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

CHAPTER 5:DTP VACCINES MARKET, BY AGE GROUP

5.1.Overview

5.1.1.Market size and forecast

5.2.Adults

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Pediatrics

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

CHAPTER 6:DTP VACCINES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Clinics

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Vaccination Centers

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:DTAP VACCINES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by product
7.2.3.Market size and forecast, by age group
7.2.4.Market size and forecast, by end user
7.2.5.Market size and forecast, by country

7.2.5.1.U.S. market size and forecast, by product
7.2.5.2.U.S. market size and forecast, by age group

7.2.6.Market size and forecast, by end users

7.2.6.1.Canada market size and forecast, by product
7.2.6.2.Canada market size and forecast, by age group

7.2.7.Market size and forecast, by end users

7.2.7.1.Mexico market size and forecast, by product
7.2.7.2.Mexico market size and forecast, by age group

7.2.8.Market size and forecast, by end users

7.3.Europe

7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by product
7.3.3.Market size and forecast, by age group
7.3.4.Market size and forecast, by end user
7.3.5.Market size and forecast, by country

7.3.5.1.Germany market size and forecast, by product
7.3.5.2.Germany market size and forecast, by age group

7.3.6.Market size and forecast, by end users

7.3.6.1.France market size and forecast, by product
7.3.6.2.France market size and forecast, by age group

7.3.7.Market size and forecast, by end users

7.3.7.1.UK market size and forecast, by product
7.3.7.2.UK market size and forecast, by age group

7.3.8.Market size and forecast, by end users

7.3.8.1.Italy market size and forecast, by product
7.3.8.2.Italy market size and forecast, by age group

7.3.9.Market size and forecast, by end users

7.3.9.1.Rest of Europe market size and forecast, by product
7.3.9.2.Rest of Europe market size and forecast, by age group

7.3.10.Market size and forecast, by end users

7.4.Asia-Pacific

7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by product
7.4.3.Market size and forecast, by age group
7.4.4.Market size and forecast, by end users
7.4.5.Market size and forecast, by country

7.4.5.1.Japan market size and forecast, by product
7.4.5.2.Japan market size and forecast, by age group

7.4.6.Market size and forecast, by end users

7.4.6.1.China market size and forecast, by product
7.4.6.2.China market size and forecast, by age group

7.4.7.Market size and forecast, by end users

7.4.7.1.Australiamarket size and forecast, by product
7.4.7.2.Australia market size and forecast, by age group

7.4.8.Market size and forecast, by end users

7.4.8.1.India market size and forecast, by product
7.4.8.2.India market size and forecast, by age group

7.4.9.Market size and forecast, by end users

7.4.9.1.Rest of Asia Pacificmarket size and forecast, by product
7.4.9.2.Rest of Asia Pacific market size and forecast, by age group

7.4.10.Market size and forecast, by end users

7.5.LAMEA

7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by product
7.5.3.Market size and forecast, by age group
7.5.4.Market size and forecast, by end users
7.5.5.Market size and forecast, by country

7.5.5.1.Brazil market size and forecast, by product
7.5.5.2.Brazil market size and forecast, by age group

7.5.6.Market size and forecast, by end users

7.5.6.1.South Africa market size and forecast, by product
7.5.6.2.South Africa market size and forecast, by age group

7.5.7.Market size and forecast, by end users

7.5.7.1.Rest of LAMEA market size and forecast, by product
7.5.7.2.Rest of LAMEA market size and forecast, by age group
7.5.8.Market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.AJ VACCINES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Product portfolio

8.2.BIONET-ASIA

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Product portfolio

8.3.GLAXOSMITHKLINE PLC (GSK)

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.JOHNSON & JOHNSON

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.MASSBIOLOGICS

8.5.1.Company overview
8.5.2.Company snapshot1
8.5.3.Product portfolio

8.6.MEIJI HOLDINGS CO., LTD. (KM BIOLOGICS CO., LTD.)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.MERCK & CO., INC.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.PANACEA BIOTEC LTD.

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.SANOFI

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.SERUM INSTITUTE OF INDIA PVT. LTD

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Product portfolio